MELBOURNE, Australia and SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
During the Quarter, Amaero continued to execute on its strategy to establish a scaled, cost-competitive U.S. domestic ...
The US State Department on Tuesday released a pared-down version of its annual report meant to catalogue human rights concerns in countries around the world. The report covers the 2024 calendar year – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results